Zhongjie Fu, PhD, received a grant from the Blind Children's Center in Los Angeles in the amount of $25,000 over 1 year, for her project, "FGF21 protects against hyperglycemia-associated ROP through modulating energy metabolism."
Ula V. Jurkunas, MD, received a grant from the National Institutes of Health in the amount of $3,431,841 over 4 years for her project, “Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency.” This grant includes work performed at Mass. Eye and Ear, Dana-Farber Cancer Institute in Boston, and Jaeb Center for Health Research in Tampa, Florida.
The National Institutes of Health (NIH) funded Schepens Eye Research Institute of Mass. Eye and Ear’s P30 core grant competitive renewal (PI: Pablo Argüeso, PhD) at $2 million over five years. This critical funding supports four shared core resources at 20 Staniford Street:
Joseph Ciolino, MD, received a Pilot and Feasibility Grant in the amount of $30,000 from the Boston Area Diabetes Endocrinology Research Center to investigate the use of dexamethasone-eluting contact lenses in animal models of diabetic retinopathy
Grayson Armstrong, MD, MPH, was selected to receive a Massachusetts Society of Eye Physicians and Surgeons (MSEPS) Advocacy Ambassador Travel Grant to attend the AAO’s 2017 Mid-Year Forum in Washington, DC. MSEPS is dedicated to the public’s direct access to ophthalmic care, and to serve the total visual health care needs of the people of Massachusetts through public and professional education, membership services,
As part of the National Eye Institute Audacious Goals Initiative, the National Institutes of Health awarded $12.4 million to six research teams to identify biological factors that affect neural regeneration in the retina. Larry Benowitz, PhD, Boston Children’s Hospital, and colleagues at Stanford University and the Scripps Research Institute, received funding to support their research toward the molecular discovery of optic nerve injury. By
Leo Kim, MD, PhD, received a grant from the E. Matilda Ziegler Foundation for the Blind, Inc. in the amount of $80,000 over three years for his project studying Runx1 in retinal neovascularization. He is working on this project in collaboration with Joseph Arboleda-Velasquez, MD, PhD.